Ez Aldeen Esawi

Ez Aldeen Esawi

Higher Degree by Research Candidate

South Australian Immunogenomics Cancer Institute

Faculty of Health and Medical Sciences

  • Journals
    Year Citation
    2024 Alkhawaja, B., Abuarqoub, D., Al-Natour, M., Alshaer, W., Abdallah, Q., Esawi, E., . . . Watts, A. G. (2024). Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery. Bioconjugate Chemistry, 35(10), 1491-1502.
    DOI
    2023 Esawi, E. I., Mahmoud, I. S., Abdullah, M. S., Abuarqoub, D. A., Ahram, M. A., & Alshaer, W. M. (2023). 1,4-Naphthoquinone Induces FcRn Protein Expression and Albumin Recycling in Human THP-1 Cells. ACS Omega, 8(18), 16491-16499.
    DOI Scopus4
    2023 Abuarqoub, D., Mahmoud, N., Alshaer, W., Mohammad, M., Ibrahim, A. A., Al-Mrahleh, M., . . . Awidi, A. (2023). Biological Performance of Primary Dental Pulp Stem Cells Treated with Gold Nanoparticles. Biomedicines, 11(9), 1-15.
    DOI Scopus1 Europe PMC1
    2023 Niemi, M. E. K., Karjalainen, J., Liao, R. G., Neale, B. M., Daly, M., Ganna, A., . . . Sedaghati-Khayat, B. (2023). Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x). Nature, 621(7977), E7-E26.
    DOI Scopus34 WoS4 Europe PMC38
    2023 Nsairat, H., Alshaer, W., Odeh, F., Esawi, E., Khater, D., Bawab, A. A., . . . Mubarak, M. S. (2023). Recent advances in using liposomes for delivery of nucleic acid-based therapeutics. OpenNano, 11, 100132.
    DOI Scopus48
    2023 Alshaer, W., Nsairat, H., Lafi, Z., Hourani, O. M., Al-Kadash, A., Esawi, E., & Alkilany, A. M. (2023). Quality by Design Approach in Liposomal Formulations: Robust Product Development. Molecules, 28(1), 19 pages.
    DOI Scopus26 WoS4 Europe PMC3
    2022 Al-Azzawi, H., Alshaer, W., Esawi, E., Lafi, Z., Abuarqoub, D., Zaza, R., . . . Awidi, A. (2022). Multifunctional nanoparticles recruiting hyaluronic acid ligand and polyplexes containing low molecular weight protamine and ATP-Sensitive DNA motif for doxorubicin delivery. Journal of Drug Delivery Science and Technology, 69, 11 pages.
    DOI Scopus7
    2022 The COVID-19 Host Genetics Initiative., & Ganna, A. (2022). A second update on mapping the human genetic architecture of COVID-19.
    DOI
    2021 Sweidan, N., Esawi, E., Ismail, M., & Alshaer, W. (2021). Anticancer Cardenolides from the aerial parts of Calortopis procera. Zeitschrift fur Naturforschung - Section C Journal of Biosciences, 76(5), 243-250.
    DOI Scopus4 WoS1 Europe PMC3
    2021 Mahmoud, I. S., Hatmal, M. M., Abuarqoub, D., Esawi, E., Zalloum, H., Wehaibi, S., . . . Alshaer, W. (2021). 1,4-Naphthoquinone Is a Potent Inhibitor of IRAK1 Kinases and the Production of Inflammatory Cytokines in THP-1 Differentiated Macrophages. ACS Omega, 6(39), 25299-25310.
    DOI Scopus18 WoS5 Europe PMC13
    2021 Esawi, E., Alshaer, W., Mahmoud, I. S., Alqudah, D. A., Azab, B., & Awidi, A. (2021). Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells. International Journal of Molecular Sciences, 22(23), 12940.
    DOI Scopus11 WoS3 Europe PMC4
    2020 Odeh, F., Nsairat, H., Alshaer, W., Ismail, M. A., Esawi, E., Qaqish, B., . . . Ismail, S. I. (2020). Aptamers chemistry: Chemical modifications and conjugation strategies. Molecules, 25(1), 51 pages.
    DOI Scopus257 WoS154 Europe PMC118

  • Book Chapters
    Year Citation
    2022 Esawi, E., Nsairat, H., Mahmoud, I. S., Lafi, Z., Al-Kadash, A., Al-Ragheb, B. A., . . . Alhaer, W. (2022). Clinical use and future perspective of aptamers. In Aptamers Engineered Nanocarriers for Cancer Therapy (pp. 481-520). Elsevier.
    DOI Scopus5
    2022 Nsairat, H., Alshaer, W., Mahmoud, I. S., Ismail, M. A., Esawi, E., Alsotari, S., & Ismail, S. I. (2022). Aptamers in Theranostic Bionanomaterials. In Bionanotechnology: Next-Generation Therapeutic Tools (pp. 130-158). BENTHAM SCIENCE PUBLISHERS.
    DOI Scopus1
Connect With Me
External Profiles